FINOMKERAMIAI OEMLESZTOEANYAGOK ALKALMAZHATOSAGI VIZSGALATA = ETUDE DES FONDANTS POUR LA FABRICATION DE CERAMIQUE FINECSETENYI J.1979; EPITOEANYAG; HUN; DA. 1979; VOL. 31; NO 12; PP. 456-461; ABS. RUS/GER/ENG; BIBL. 7 REF.Article

RELATION ENTRE LA GRANULARITE ET LA MICROSTRUCTURE DE LA PORCELAINEFARKAS O; CSETENYI J.1972; EPITOEANYAG; MAGYAR.; DA. 1972; VOL. 24; NO 10; PP. 369-372Serial Issue

A NEW DECOMPOSITION TECHNIQUE FOR THE DETERMINATION OF SULFUR OR SULPHUR-35 IN ORGANIC COMPOUNDS AS SULPHURIC ACID.GACS I; VARGAY Z; CSETENYI J et al.1977; MIKROCHIM. ACTA; AUTR.; DA. 1977; VOL. 2; NO 3-4; PP. 107-119; ABS. ALLEM.; BIBL. 1 P.Article

IMINOSTILBENE. A METABOLITE OF CARBAMAZEPINE ISOLATED FROM RAT URINECSETENYI J; BAKER KM; FRIGERIO A et al.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 4; PP. 340-341; BIBL. 4 REF.Serial Issue

ALBUMIN MACROAGGREGATES CONTAINING ^113MIN-SULFIDE (^113MINSMAA): TECHNIQUE FOR THE PREPARATION OF A NEW LUNG SCANNING AGENT = LES MACROAGREGATS D'ALBUMINE CONTENANT DU SULFURE DE ^113MIN, (^113MINSMAA): TECHNIQUE POUR LA PREPARATION D'UN NOUVEL AGENT POUR LA SCINTIGRAPHIE DES POUMONSCSETENYI J; SZAMEL S; FUZI M et al.1974; RADIOBIOL. RADIOTHERAP.; ALLEM.; DA. 1974; VOL. 15; NO 1; PP. 55-61; ABS. RUSSE; BIBL. 18REF.Article

PRELIMINARY PHARMACOLOGICAL STUDIES WITH 1,6-DIMESYL-2,3-4,5-DIANHYDRO-L-IDITOL IN PATIENTS WITH CANCER.CSETENYI J; BIHARI V; SZAMEL SI et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 9; PP. 675-676; BIBL. 3 REF.Article

10,11-DIHYDRO-10,11-DIHYDROXY-5H-DIBENZ (B,F) AZEPINE-5-CARBOXAMIDE, A METABOLITE OF CARBAMAZEPINE ISOLATED FROM HUMAN AND RAT URINEBAKER KM; CSETENYI J; FRIGERIO A et al.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 6; PP. 703-705; BIBL. 10REF.Serial Issue

METABOLISM AND PHARMACOKINETICS OF DIBROMODULCITOL (DBD, NSC-104800) IN MAN. II: PHARMACOKINETICS OF DBD = METABOLISME ET PHARMACOCINETIQUE DU DIBROMODULCITOL (DBD, NSC-104800) CHEZ L'HOMME. II: PHARMACOCINETIQUE DU DBDHORVATH IP; CSETENYI J; HINDY I et al.1982; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 11; PP. 1211-1219; ABS. ENG; BIBL. 10 REF.; GRAPHArticle

CHEMICAL REACTIVITY AND INTRACAVITARY APPLICATION OF ALKYLATING SUGAR ALCOHOL DERIVATIVESKERPEL FRONIUS S; CSETENYI J; HEGEDUES L et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 109-114; BIBL. 18 REF.Article

METABOLISM AND PHARMACOKINETICS OF DIBROMODULCITOL (DBD, NSC-104800) IN MAN. I: METABOLITES OF DBDHORVATH JP; CSETENYI J; KERPEL FRONIUS S et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 3; PP. 337-344; BIBL. 17 REF.Article

UPTAKE OF LABELED DIANHYDROGALACTITOL INTO HUMAN GLIOMAS AND NERVOUS TISSUE.ECKHARDT S; CSETENYI J; HORVATH IP et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 5; PP. 841-847; BIBL. 22 REF.Article

Pharmacokinetic studies of [¹⁴C]-flumecinol in humansKLEBOVICH, I; CSETENYI, J; KERPEL-FRONIUS, S et al.Arzneimittel-Forschung. 1987, Vol 37, Num 3, pp 368-371, issn 0004-4172Article

Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBDHORVATH, I. P; CSETENYI, J; KERPEL-FRONIUS, S et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 2, pp 163-171, issn 0277-5379Article

The role of comparative pharmacokinetics int the planning of human dose escalation: the experience with diacetyldianhydrogalactitolKERPEL-FRONIUS, S; ERDELYI-TOTH, V; SOMFAI-RELLE, S et al.Cancer chemotherapy and pharmacology. 1988, Vol 22, Num 2, pp 109-113, issn 0344-5704Article